ENTRY       D07564                      Drug
NAME        Allopurinol sodium;
            Aloprim (TN)
PRODUCT     ALOPRIM (Mylan Institutional LLC)
            ALOPRIM (Mylan Institutional LLC)
  GENERIC   ALLOPURINOL (Fresenius Kabi USA)
            ALLOPURINOL (Gland Pharma Limited)
            ALLOPURINOL SODIUM (Hikma Pharmaceuticals USA)
FORMULA     C5H3N4O. Na
EXACT_MASS  158.0205
MOL_WEIGHT  158.0933
CLASS       Cardiovascular agent
             DG01503  Xanthine dehydrogenase inhibitor
            Musculo-skeletal system agent
             DG03130  Xanthin oxidase inhibitor
            Metabolizing enzyme inhibitor
             DG01634  CYP1A2 inhibitor
REMARK      ATC code: M04AA01
            Chemical structure group: DG00779
            Product (DG00779): D00224<JP/US> D07564<US>
EFFICACY    Gout suppressant, Uric acid biosynthesis inhibitor, Xanthine oxidase inhibitor
TARGET      XDH [HSA:7498] [KO:K00106]
  PATHWAY   hsa00230(7498)  Purine metabolism
INTERACTION CYP inhibition: CYP1A2 [HSA:1544]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M04 ANTIGOUT PREPARATIONS
               M04A ANTIGOUT PREPARATIONS
                M04AA Preparations inhibiting uric acid production
                 M04AA01 Allopurinol
                  D07564  Allopurinol sodium &lt;US&gt;
            USP drug classification [BR:br08302]
             Antigout Agents
              Allopurinol
               D07564  Allopurinol sodium
             Antineoplastics
              Antineoplastic Adjuncts/Mitigators
               Allopurinol
                D07564  Allopurinol sodium
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01503  Xanthine dehydrogenase inhibitor
               DG00779  Allopurinol
                D07564  Allopurinol sodium
             Musculo-skeletal system agent
              DG03130  Xanthin oxidase inhibitor
               DG00779  Allopurinol
                D07564  Allopurinol sodium
             Metabolizing enzyme inhibitor
              DG01634  CYP1A2 inhibitor
               DG00779  Allopurinol
                D07564  Allopurinol sodium
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Xanthine dehydrogenase/oxidase
                XDH
                 D07564  Allopurinol sodium &lt;US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D07564
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D07564
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01503  Xanthine dehydrogenase inhibitor
               DG00779  Allopurinol
             Musculo-skeletal system agent
              DG03130  Xanthin oxidase inhibitor
               DG00779  Allopurinol
             Metabolizing enzyme inhibitor
              DG01634  CYP1A2 inhibitor
               DG00779  Allopurinol
DBLINKS     CAS: 17795-21-0
            PubChem: 51091885
            LigandBox: D07564
ATOM        11
            1   C8y C    24.0800  -17.9200
            2   C8y C    24.0800  -19.3200
            3   C8y C    25.2700  -17.2200
            4   N4x N    22.7500  -17.5000
            5   N5x N    25.2700  -20.0200
            6   C8x C    22.7500  -19.7400
            7   N5x N    26.4600  -17.9200
            8   O1a O    25.2700  -15.8200 #-
            9   N5x N    21.9100  -18.6200
            10  C8x C    26.4600  -19.3200
            11  Z   Na   29.6800  -18.1300 #+
BOND        11
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 2
            7     3   8 1
            8     4   9 1
            9     5  10 2
            10    6   9 2
            11    7  10 1
///
